1. A Bayesian dose‐finding design incorporating toxicity data from multiple treatment cycles. (15th September 2016) Authors: Yin, Jun; Qin, Rui; Ezzalfani, Monia; Sargent, Daniel J.; Mandrekar, Sumithra J. Journal: Statistics in medicine Issue: Volume 36:Number 1(2017) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non–Small-Cell Lung Cancer. Issue 1 (January 2015) Authors: Zhao, Yujie; Foster, Nathan R.; Meyers, Jeffrey P.; Thomas, Sachdev P.; Northfelt, Donald W.; Rowland, Kendrith M.; Mattar, Bassam I.; Johnson, David B.; Molina, Julian R.; Mandrekar, Sumithra J.; Schild, Steven E.; Bearden, James D.; Aubry, Marie-Christine; Adjei, Alex A. Journal: Journal of thoracic oncology Issue: Volume 10:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin, and Concurrent Thoracic Radiation Therapy for Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group (NCCTG)-N0321. Issue 1 (January 2015) Authors: Zhao, Yujie; Foster, Nathan R.; Meyers, Jeffrey P.; Thomas, Sachdev P.; Northfelt, Donald W.; Rowland, Kendrith M.; Mattar, Bassam I.; Johnson, David B.; Molina, Julian R.; Mandrekar, Sumithra J.; Schild, Steven E.; Bearden, James D.; Aubry, Marie-Christine; Adjei, Alex A. Journal: Journal of thoracic oncology Issue: Volume 10:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance). (24th December 2019) Authors: Parikh, Kaushal; Mandrekar, Sumithra J.; Allen‐Ziegler, Katie; Esplin, Brandt; Tan, Angelina D.; Marchello, Benjamin; Adjei, Alex A.; Molina, Julian R. Journal: Oncologist Issue: Volume 25:Number 6(2020) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. An adaptive multi-stage phase I dose-finding design incorporating continuous efficacy and toxicity data from multiple treatment cycles. Issue 2 (4th March 2019) Authors: Du, Yu; Yin, Jun; Sargent, Daniel J.; Mandrekar, Sumithra J. Journal: Journal of biopharmaceutical statistics Issue: Volume 29:Issue 2(2019) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA. (May 2022) Authors: Remon, Jordi; Lacas, Benjamin; Herbst, Roy; Reck, Martin; Garon, Edward B.; Scagliotti, Giorgio V.; Ramlau, Rodryg; Hanna, Nasser; Vansteenkiste, Johan; Yoh, Kiyotaka; Groen, Harry J.M.; Heymach, John V.; Mandrekar, Sumithra J.; Okamoto, Isamu; Neal, Joel W.; Heist, Rebecca S.; Planchard, David; ... Journal: European journal of cancer Issue: Volume 166(2022) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical trial designs incorporating predictive biomarkers. (February 2016) Authors: Renfro, Lindsay A.; Mallick, Himel; An, Ming-Wen; Sargent, Daniel J.; Mandrekar, Sumithra J. Journal: Cancer treatment reviews Issue: Volume 43(2016) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Definitions and statistical properties of master protocols for personalized medicine in oncology. Issue 2 (4th March 2018) Authors: Renfro, Lindsay A.; Mandrekar, Sumithra J. Journal: Journal of biopharmaceutical statistics Issue: Volume 28:Issue 2(2018) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dose‐finding designs using a novel quasi‐continuous endpoint for multiple toxicities. (21st January 2013) Authors: Ezzalfani, Monia; Zohar, Sarah; Qin, Rui; Mandrekar, Sumithra J.; Deley, Marie‐Cécile Le Journal: Statistics in medicine Issue: Volume 32:Number 16(2013) Page Start: 2728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. GBOIN: A Unified Model-Assisted Phase I Trial Design Accounting for Toxicity Grades, and Binary or Continuous End Points. Issue 2 (16th February 2018) Authors: Mu, Rongji; Yuan, Ying; Xu, Jin; Mandrekar, Sumithra J.; Yin, Jun Journal: Journal of the Royal Statistical Society Issue: Volume 68:Issue 2(2019) Page Start: 289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗